These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25661257)

  • 1. The phospholipase D superfamily as therapeutic targets.
    Frohman MA
    Trends Pharmacol Sci; 2015 Mar; 36(3):137-44. PubMed ID: 25661257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for PLD Inhibition in Cancer and Thrombotic Disease.
    Salazar C; Frohman MA
    Handb Exp Pharmacol; 2020; 259():79-88. PubMed ID: 31541323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.
    Jenco JM; Rawlingson A; Daniels B; Morris AJ
    Biochemistry; 1998 Apr; 37(14):4901-9. PubMed ID: 9538008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
    Burkhardt U; Beyer S; Klein J
    Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation.
    Lien LM; Lu WJ; Chen TY; Lee TY; Wang HH; Peng HY; Chen RJ; Lin KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.
    Lavieri RR; Scott SA; Selvy PE; Kim K; Jadhav S; Morrison RD; Daniels JS; Brown HA; Lindsley CW
    J Med Chem; 2010 Sep; 53(18):6706-19. PubMed ID: 20735042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.
    Kim JH; Lee BD; Kim Y; Lee SD; Suh PG; Ryu SH
    J Immunol; 1999 Nov; 163(10):5462-70. PubMed ID: 10553072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
    Roth E; Frohman MA
    Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.
    Lavieri R; Scott SA; Lewis JA; Selvy PE; Armstrong MD; Alex Brown H; Lindsley CW
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2240-3. PubMed ID: 19299128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes.
    Jang YH; Ahn BH; Namkoong S; Kim YM; Jin JK; Kim YS; Min do S
    Cell Signal; 2008 Dec; 20(12):2198-207. PubMed ID: 18694819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.
    Su W; Chen Q; Frohman MA
    Future Oncol; 2009 Nov; 5(9):1477-86. PubMed ID: 19903073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel Ca2+-dependent, phosphatidylethanolamine-hydrolyzing phospholipase D in yeast bearing a disruption in PLD1.
    Waksman M; Tang X; Eli Y; Gerst JE; Liscovitch M
    J Biol Chem; 1997 Jan; 272(1):36-9. PubMed ID: 8995222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade.
    Slaaby R; Du G; Altshuller YM; Frohman MA; Seedorf K
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):613-9. PubMed ID: 11042115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid.
    Sarri E; Pardo R; Fensome-Green A; Cockcroft S
    Biochem J; 2003 Jan; 369(Pt 2):319-29. PubMed ID: 12374567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and physiological roles for phospholipase D1 in cancer.
    Zhang Y; Frohman MA
    J Biol Chem; 2014 Aug; 289(33):22567-22574. PubMed ID: 24990946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting phospholipase D in cancer, infection and neurodegenerative disorders.
    Brown HA; Thomas PG; Lindsley CW
    Nat Rev Drug Discov; 2017 May; 16(5):351-367. PubMed ID: 28209987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D is a target for inhibition of astroglial proliferation by ethanol.
    Burkhardt U; Wojcik B; Zimmermann M; Klein J
    Neuropharmacology; 2014 Apr; 79():1-9. PubMed ID: 24262632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.
    Mateos MV; Kamerbeek CB; Giusto NM; Salvador GA
    Int J Biochem Cell Biol; 2014 Oct; 55():119-28. PubMed ID: 25172550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis.
    Corrotte M; Chasserot-Golaz S; Huang P; Du G; Ktistakis NT; Frohman MA; Vitale N; Bader MF; Grant NJ
    Traffic; 2006 Mar; 7(3):365-77. PubMed ID: 16497229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.